Thyrocare Technologies Limited
NSE:THYROCARE.NS
978 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Thyrocare Technologies Limited |
Symbool | THYROCARE.NS |
Munteenheid | INR |
Prijs | 978 |
Beurswaarde | 51,787,740,600 |
Dividendpercentage | 0% |
52-weken bereik | 533.5 - 998.55 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Rahul Franklin Guha |
Website | https://www.thyrocare.com |
An error occurred while fetching data.
Over Thyrocare Technologies Limited
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)